Notices and Activity Reports

【IMPORTANT]】THE MARCH OPEN STUDY SESSION WILL BE HELD VIA ZOOM.

To whom it may concern

In order to prevent the spread of the new coronavirus both domestically and internationally,
a large scale of self-restraint is in place and educational institutions are closed.
We hope that everyone is in good health and that the situation is coming to an end.

In addition, due to a recommendation to refrain from various types of meetings,
the monthly open study sessions
will be held on the web via ZOOM for the month of March.
We will also be holding our monthly open study sessions on the web via ZOOM in March.
If you have any questions, please contact us.

◆_________◆

Intestinal Flora Transplantation Clinical Research Foundation
Secretariat
Tel: 06-6809-5296
E-mail : info@fmt-japan.org
◆_________◆

Articles about other Notices and Activity Reports

April 03, 2024

【Event】 Dr. Shirotani will speak at the 7th Annual Conference of the Japanese Society of Preemptive Clinical Medicine

Dr. Masahiko Shirotani, Executive Director of the Luke’s Ashiya Clinic, will deliver a special lecture at the 7th Annual Conference of the Japanese Society of Preemptive Medicine to be held on June 22 (Sat.) and 23 (Sun.), 2024. Dr. Zen Tanaka, President of Tanaka Clinic, Nizenkai Medical Corporation, will be the chairperson. Lecture Contents Special […]

March 04, 2024 Academic Conference

〈Registration Start〉8th Annual Conference

We are pleased to announce that the 8th Annual Conference will be held again this year. (Venue and online)Anyone is welcome to attend, not only healthcare professionals, but also the general public, students, etc. Date and Time Sunday, September 22, 2024Start 11:00 am (Registration 10:30 am) – Closing at 5:00 pm *General Meeting: Held before […]

February 04, 2024

Interview with Goro Tsukamoto at the 7th Annual Meeting

‘Gut Flora Transplantation Clinical Study Group of Experts〜Aiming for easier access to treatment, we are challenging research and development.Pharmacist, Doctor of Engineering Goro Tsukamoto: Former Director and General Manager of Drug Discovery Research Institute, Bell Boss, Former Visiting Professor, University of Pittsburgh, USA, Former Professor, Nagaoka University of Technology The world’s first migraine drug, invented […]